Shay Capital’s Acceleron Pharma XLRN Stock Holding History

Shay Capital’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,878	Closed	-$323K	–	739
2021 Q3	$323K	Buy	+1,878	New	+$246K	0.04%	322

Shay Capital's XLRN Position: Q4 2021 in Review

Shay Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,878 shares — an estimated $323K sold.

Shay Capital first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $323K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Shay Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Shay Capital sold 1,878 Acceleron Pharma shares in Q4 2021, an estimated $323K.
Shay Capital first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Shay Capital's Acceleron Pharma position peaked at $323K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Shay Capital's 13F filing for Q4 2021, filed 14 Feb 2022.